Exact Sciences Corporation
EXAS
$43.04
-$3.31-7.14%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | -1.03B | -214.04M | -175.01M | -240.23M | -204.15M |
Total Depreciation and Amortization | 214.86M | 215.88M | 213.37M | 210.81M | 206.61M |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 1.08B | 239.06M | 157.19M | 193.15M | 154.00M |
Change in Net Operating Assets | -56.01M | -7.89M | -76.88M | -51.71M | -342.00K |
Cash from Operations | 210.54M | 233.02M | 118.66M | 112.02M | 156.12M |
Capital Expenditure | -135.99M | -134.60M | -133.62M | -132.48M | -124.19M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -45.00M | -47.91M | -52.91M | -52.91M | -52.91M |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -261.17M | -284.54M | -231.77M | -19.31M | 226.78M |
Cash from Investing | -442.16M | -467.05M | -418.30M | -204.70M | 49.68M |
Total Debt Issued | 266.75M | 266.75M | 266.75M | 0.00 | 137.98M |
Total Debt Repaid | -50.00M | -50.00M | -50.00M | -- | -- |
Issuance of Common Stock | 34.24M | 33.84M | 32.78M | 30.58M | 31.54M |
Repurchase of Common Stock | -1.37M | -1.37M | -1.37M | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -17.75M | -17.81M | -16.44M | -7.41M | -9.75M |
Cash from Financing | 231.87M | 231.41M | 231.73M | 23.17M | 159.77M |
Foreign Exchange rate Adjustments | -3.29M | 2.37M | -734.00K | -369.00K | 1.32M |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -3.04M | -242.00K | -68.64M | -69.88M | 366.89M |